Radiesse 1.5: A Professional Guide to Handling, Storage, and Reconstitution

Radiesse 1.5 is a biostimulator composed of calcium hydroxylapatite (CaHA) microspheres suspended in an aqueous gel. It is designed to stimulate natural collagen production. Professionals stock Radiesse 1.5 in a pre-filled syringe format, which typically contains 1.5 mL of product. Understanding its composition is key to proper handling, as the viscous gel requires specific reconstitution techniques for certain applications. This product is distinct from other biostimulators like Sculptra (2 vials) which comes as a lyophilized powder, requiring different preparation steps. For a broader range of similar professional products, refer to our Skinbooster / biostimulator catalog.

Upon receiving a shipment of Radiesse 1.5, professionals should conduct an immediate and thorough inspection of the packaging. Verify that the outer carton is undamaged, sealed, and that the product name, strength (1.5 mL), manufacturer (Merz, USA), lot number, and expiration date are clearly visible and match the order. Each box should contain one sterile, pre-filled syringe. Any signs of tampering, damage, or compromised seals should be documented and reported to the supplier promptly to ensure product authenticity and safety.

Maintaining the specified storage conditions for unopened Radiesse 1.5 is critical to preserve its quality and efficacy. The product should be stored at controlled room temperature, typically between 15°C to 25°C (59°F to 77°F). It must not be frozen. Direct sunlight and excessive heat should be avoided. Adhering to these temperature parameters helps prevent degradation of the CaHA microspheres and the gel vehicle. Proper inventory management, including 'first-in, first-out' (FIFO) principles, is advised to ensure products are used before their expiration dates. This is a common requirement across many professional aesthetic products, similar to guidelines found in the VOM Light: A Professional Guide to Handling and Storage Prot article.

Radiesse 1.5, while supplied in a pre-filled syringe, often requires reconstitution or dilution with sterile saline for specific professional protocols. The objective of dilution is to alter the product's rheological properties and achieve desired aesthetic outcomes. Common diluents include sterile 0.9% sodium chloride for injection, sometimes combined with lidocaine for patient comfort. While specific dilution ratios are determined by the treating professional's clinical judgment and desired application, commonly cited ranges are from 1:0.8 to 1:2 or even higher for specific biostimulatory treatments. It is crucial to use only sterile, pyrogen-free diluents and to follow aseptic techniques rigorously. For smaller volume applications, professionals might consider products like Radiesse 0.8.

Once the required dilution ratio is determined, the preparation process involves careful, aseptic steps:

1. Sanitize: Clean the syringe's luer-lock connection with an alcohol swab.
2. Attach Needle/Cannula: Securely attach a sterile needle or cannula of appropriate gauge.
3. Draw Diluent: Carefully draw the predetermined volume of sterile diluent (e.g., saline, lidocaine) into the Radiesse syringe. Ensure no air bubbles are introduced.
4. Mix: After drawing the diluent, gently rotate and invert the syringe for several minutes to achieve a homogenous mixture. Avoid vigorous shaking, which can create foam or damage the microspheres. Some professionals prefer to let the reconstituted product sit for a period (e.g., 30 minutes to 2 hours) before use to allow for complete hydration and dispersion.
5. Inspect: Visually inspect the syringe contents to confirm a uniform, consistent suspension free of clumps or particulate matter before preparation for administration.

After reconstitution, the stability of Radiesse 1.5 may vary based on the diluent used and storage conditions. Manufacturer guidelines typically advise using the product within a specified timeframe, often within 24-72 hours, when stored aseptically at room temperature. Professionals should always refer to the latest manufacturer's instructions for specific post-reconstitution stability data. Any unused portion beyond the recommended stability period should be discarded safely. Maintaining sterility throughout this phase is paramount to prevent contamination and ensure patient safety.

Proper disposal of all used Radiesse 1.5 syringes, needles, cannulas, and any contaminated materials is a professional imperative. All sharps must be immediately placed into an approved, puncture-resistant sharps container. Other contaminated waste should be disposed of according to local, regional, and national biohazard waste regulations. Adherence to these protocols protects staff, patients, and the environment from potential hazards.